deltatrials
Unknown NCT00221923

African Descent and Glaucoma Evaluation Study

African Descent and Glaucoma Evaluation Study (Formerly African Americans With Glaucoma Study)

Sponsor: National Eye Institute (NEI)

Updated 9 times since 2017 Last updated: Jul 2, 2021 Started: Sep 30, 2002 Primary completion: Jan 31, 2022 Completion: Jul 31, 2022

A observational or N/A phase clinical study on Primary Open Angle Glaucoma, this trial is ongoing. The trial is conducted by National Eye Institute (NEI) and has accumulated 9 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Aug 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: Enrolling By InvitationUnknown Status

  4. Sep 2021 — Aug 2023 [monthly]

    Enrolling By Invitation

  5. Jan 2021 — Sep 2021 [monthly]

    Enrolling By Invitation

Show 4 earlier versions
  1. Jul 2019 — Jan 2021 [monthly]

    Enrolling By Invitation

    Status: Unknown StatusEnrolling By Invitation

  2. Jun 2018 — Jul 2019 [monthly]

    Unknown Status

  3. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NANone

  4. Jan 2017 — Apr 2018 [monthly]

    Unknown Status NA

    First recorded

Sep 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Eye Institute (NEI)
  • University of California, San Diego
Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Birmingham, United States
  • La Jolla, United States
  • New York, United States